Cart
sales@molnova.com
Home - Products - MAPK/ERK Signaling - ERK - VX-11e

VX-11e

CAS No. 896720-20-0

VX-11e ( VX 11e )

Catalog No. M16451 CAS No. 896720-20-0

A potent, selective, and orally bioavailable inhibitor of ERK2 with Ki of <2 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 45 In Stock
5MG 81 In Stock
10MG 112 In Stock
25MG 214 In Stock
50MG 340 In Stock
100MG 527 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Group Booking Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    VX-11e
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, selective, and orally bioavailable inhibitor of ERK2 with Ki of <2 nM.
  • Description
    A potent, selective, and orally bioavailable inhibitor of ERK2 with Ki of <2 nM; shows >200-fold selectivity over GSK3, Aurora A, CDK2, FLT3, etc; significantly inhibits CKAP2 overexpression-induced cell proliferation, migration and invasion in SiHa cells.
  • Synonyms
    VX 11e
  • Pathway
    MAPK/ERK Signaling
  • Target
    ERK
  • Recptor
    AuroraA;CDK2;ERK2;FLT3;GSK-3
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    896720-20-0
  • Formula Weight
    500.35
  • Molecular Formula
    C24H20Cl2FN5O2
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    O=C(C1=CC(C2=NC(NC3=CC=C(F)C=C3Cl)=NC=C2C)=CN1)N[C@@H](C4=CC=CC(Cl)=C4)CO
  • Chemical Name
    1H-Pyrrole-2-carboxamide, 4-[2-[(2-chloro-4-fluorophenyl)amino]-5-methyl-4-pyrimidinyl]-N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Aronov AM, et al. J Med Chem. 2009 Oct 22;52(20):6362-8.
2. Krepler C, et al. Clin Cancer Res. 2016 Apr 1;22(7):1592-602.
3. Guo QS, et al. Sci Rep. 2017 May 18;7(1):2117.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • AZD0364

    AZD0364 (AZD-0364) is a potent, selective, orally active ERK1/2 inhibitor for treatment of NSCLC.

  • Byakangelicol

    Byakangelicol may inhibit P-gp expressed at the BBB even under in vivo conditions.

  • Officinalisinin I

    Officinalisinin I can effectively reduce the blood glucose and protect nerve injuryin diabetic mice.

Sign In Join Free